We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tekcapital Plc | LSE:TEK | London | Ordinary Share | GB00BKXGY798 | ORD �0.004 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.20 | 2.45% | 8.35 | 8.00 | 8.70 | 8.35 | 8.25 | 8.25 | 391,246 | 15:13:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 615k | -12.75M | -0.0715 | -1.17 | 14.88M |
TIDMTEK
Tekcapital plc
01 March 2017
1 March 2017
Tekcapital plc
("Tekcapital" or the "Company")
BELLUSCURA LTD LAUNCHES WIRE CADDY(TM) IN USA
Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Ltd ("Belluscura") has launched its Wire Caddy(TM) product in the United States.
The Wire Caddy(TM) is an innovative wire management system that provides lubrication and organization during multi-wire, multi-exchange operating room cases, such as cardiology interventions, uterine fibroid embolizations and tibial angioplasties.
The Wire Caddy(TM) was designed by interventional radiologist Dr Shaun Samuels to address unique challenges in complex surgical procedures, especially those involving multi-wire and multi-exchange cases. Its unobtrusive positioning allows quick access to lubricated guidewires during surgical procedures in interventional radiology, catheterization laboratory, vascular suite and other operating room operations. Belluscura's Wire Caddy(TM) is particularly useful for single operators, interventional radiology trainees, fellows and residents.
Belluscura's Chief Executive Officer Bob Rauker said:
"Wire Caddy(TM) is an excellent component in our product portfolio, which offers premium and affordable solutions to meet the needs of the patient and healthcare providers".
About Belluscura:
Belluscura Limited is a global medical device company founded in Oxford, England. Its mission is to make healthcare more affordable for patients and their providers by providing proprietary medical devices across a wide variety of treatment and diagnostic disciplines. Belluscura's products were originally developed by leading medical device companies or research centres, and with its unique business model it is able to offer these devices at affordable prices. To learn more about Belluscura please visit www.belluscura.com.
Tekcapital owns approximately 65% of the share capital of Belluscura.
For further information, please contact:
Tekcapital Plc Clifford M. Gross, Ph.D. info@tekcapital.com Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656 Jeremy Porter / Alex Brearley Dowgate Capital Stockbrokers (Joint Broker) +44 (0) 1293 517744 David Poutney / James Serjeant Walbrook PR Ltd +44 (0) 20 7933 8780 Paul Cornelius / Helen Cresswell tekcapital@walbrookpr.com / Sam Allen
Tekcapital plc - The World's Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com
LEI: 213800GOJTOV19FIFZ85 http://www.rns-pdf.londonstockexchange.com/rns/1208Y_-2017-2-28.pdf
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABRGDDSBDBGRI
(END) Dow Jones Newswires
March 01, 2017 02:01 ET (07:01 GMT)
1 Year Tekcapital Chart |
1 Month Tekcapital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions